Ischemic heart disease decisions — 2025

The Board granted an effective date of October 15, 2018, for the award of service connection for coronary artery disease.

The Board granted a 100 percent evaluation for the Veteran's coronary artery disease based on a workload of three or fewer metabolic equivalents (METs) resulting in symptoms of heart failure.

The veteran's appeal for service connection for erectile dysfunction, a heart condition, bilateral hearing loss, and bilateral knees was dismissed as it was not timely filed.

The Board denied an initial compensable disability rating for hypothyroidism but granted an earlier effective date of January 26, 2022, for the award of service connection for hypothyroidism. The Board also remanded a claim for service connection for valvular heart disease.

The Board denied the Veteran's claims for earlier effective dates for the awards of service connection and increased ratings, finding that no evidence supports an earlier date than April 1, 2024.

The Board denied a rating higher than 60 percent for heart disease and a rating higher than 40 percent for bilateral hearing loss, but restored the 60 percent rating for gout effective June 1, 2020. The claims for ratings higher than 30 percent for right shoulder disability were remanded.

The Board denied the veteran's claims for an increased rating for coronary artery disease, service connection for bladder cancer and chronic obstructive pulmonary disease.

The Board denied service connection for a heart disability, right and left upper extremity disabilities (residuals of cold weather injuries), right and left lower extremity disabilities (residuals of cold weather injuries), bilateral hearing loss, and tinnitus.

The appeal for service connection for a heart disability and Parkinson's disease was dismissed as a matter of law due to a procedural defect.

The Board denied increased ratings for bladder cancer, heart disease, PTSD, back condition, and sciatic nerve radiculopathy.

The Board granted service connection for coronary artery disease, Type II diabetes, and hypertension under the PACT Act. Peripheral arterial diseases were also granted as secondary to service-connected conditions.

The Board remands the issue of entitlement to service connection for the Veteran's cause of death, for purposes of entitlement to dependency and indemnity compensation (DIC), as further development is necessary.

The Board granted service connection for coronary artery disease as secondary to sleep apnea and denied the other claims on appeal.

The Board granted a 60 percent rating for coronary artery disease from September 1, 2020 to February 22, 2021 and denied earlier effective dates for the assignment of a 100 percent rating for coronary artery bypass surgery and service connection for an anterior chest scar.

The Board granted an initial rating of 30 percent for cardiomyopathy and heart murmur with coronary artery disease, denied a compensable rating for hypertension, and denied an increased rating for degenerative arthritis and degenerative disc disease of the lumbar spine.

The Board remands the claims for service connection for heart disability, diabetes mellitus, type II, and bilateral eye disabilities due to inadequate medical opinions regarding their relationship to toxic exposure during active duty.

The Board remands the claims for service connection for coronary artery disease and prostate cancer, to include as due to herbicide exposure or a medically unexplained chronic multi-symptom illness (MUCMI), for further development of the record.

The Board remands the claims for service connection for a heart disorder and sleep disorder due to pre-decisional duty to assist errors.

The Board remands the matters for further development, including obtaining potentially relevant medical records and readjudicating the claims.

The Board remands the claim for service connection for a heart disability for initial AOJ consideration on the merits, as new and relevant evidence has been received since the December 2018 rating decision.